Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-02-04

Clinical Trial Update: Portable Ultrasound to Predict Heart Failure Readmission Risk [NA]

View source ↗

Summary

A trial investigating portable ultrasound to predict heart failure readmission risk has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Guthrie Clinic | Conditions: Heart Failure, Patient Readmission | NA | Status: WITHDRAWN